GD
39
-2
BBY
48
2
BK
68
-3
ECL
57
-2
BXP
49
-3
FOX
53
-2
WYNN
32
2
NWL
66
-3
DG
21
-6
NRG
40
3
CME
56
-3
XRAY
50
4
HAS
37
-4
PVH
62
2
TAP
61
-3
SYK
55
-4
L
58
3
CINF
31
2
MDLZ
36
2
SO
48
-2
GD
39
-2
BBY
48
2
BK
68
-3
ECL
57
-2
BXP
49
-3
FOX
53
-2
WYNN
32
2
NWL
66
-3
DG
21
-6
NRG
40
3
CME
56
-3
XRAY
50
4
HAS
37
-4
PVH
62
2
TAP
61
-3
SYK
55
-4
L
58
3
CINF
31
2
MDLZ
36
2
SO
48
-2
Financhill
Back

ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN Vs. Aligos Therapeutics Industry Stock Comparison

Sell
49

SMHB
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN

Last Price:
5.61
Seasonality Move:
-0.95%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.28
Seasonality Move:
10.65%
Sell
49
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN (SMHB) is a Sell

Is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN a Buy, Sell or Hold?

  • The current ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN [SMHB] share price is $5.64. The Score for SMHB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SMHB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SMHB Stock Price Chart

What is ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN's stock price today?

  • The ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN share price today is $5.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMHB is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMHB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 44.91 Sell
Chaikin Money Flow: -5021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.61 - 5.81) Sell
Bollinger Bands (100): (5.67 - 6.23) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

SMHB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.67 Sell
20-day SMA: 5.68 Sell
50-day SMA: 5.85 Sell
200-day SMA: 6.01 Sell
8-day EMA: 5.66 Sell
20-day EMA: 5.71 Sell
50-day EMA: 5.81 Sell
200-day EMA: 6.01 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN Earnings Growth & SMHB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):